Establishment Labs Executive and Leadership Team

Peter Caldini, the Chief Executive Officer at Establishment Labs, directs the company's overarching strategy and operational execution. Caldini guides the organization's mission to enhance women's health and wellness through advanced Femtech solutions. This leadership involves driving market expansion for the company's portfolio of breast health, aesthetics, and reconstruction technologies. Caldini ensures that scientific innovation and engineering excellence remain central to product development, aligning with the company's dedication to improving patient outcomes globally. The Chief Executive Officer oversees the integration of new breakthroughs, such as the Mia Femtech experience, into the existing product lines. Peter Caldini's focus is on sustainable growth and solidifying Establishment Labs' position as a leader in medical technology for women.

Juan Chacón-Quirós, the Founder & Chief Executive Officer at Establishment Labs, established the company's vision for transforming women's health. Chacón-Quirós champions the integration of science, engineering, and technology to deliver innovative Femtech solutions. This foundational leadership drives the development and global dissemination of products focused on breast health, aesthetics, and reconstruction. The Founder & Chief Executive Officer ensures the company's portfolio, including the Motiva Flora® tissue expander and Mia Femtech, reflects a commitment to superior patient outcomes and advanced medical technology. Chacón-Quirós oversees the strategic direction that supports over 200 patent applications and numerous scientific studies. Juan Chacón-Quirós's enduring influence shapes the company's culture of innovation and dedication to women's wellness.

Sandra Harris, the Chief Financial Officer at Establishment Labs, manages the company's financial strategy and fiscal operations. Harris oversees all aspects of financial planning, reporting, and capital allocation to support Establishment Labs' growth in the global medical technology market. This role involves ensuring financial stability and driving profitability across the company's Femtech solutions for breast health and reconstruction. The Chief Financial Officer collaborates with executive leadership to secure funding for research and development, supporting the company's extensive patent portfolio and scientific initiatives. Harris directs the financial management of international operations, ensuring compliance with global financial regulations. Sandra Harris's expertise is critical for sustaining the company's expansion and its commitment to improving women's health outcomes.

Roberto De Mezerville, the Chief Technology Officer at Establishment Labs, spearheads the company's technological innovation and product development. De Mezerville directs the engineering and scientific teams responsible for creating advanced Femtech solutions in breast health, aesthetics, and reconstruction. This leadership ensures the integration of cutting-edge science and technology into products like the Motiva Flora® tissue expander and Mia Femtech. The Chief Technology Officer oversees the company's robust intellectual property strategy, managing over 200 patent applications worldwide. De Mezerville guides the technical execution that supports the company's extensive scientific studies and peer-reviewed publications. Roberto De Mezerville's vision is pivotal in maintaining Establishment Labs' technological edge and advancing women's wellness through engineering excellence.

Ross Mansbach, the Chief Compliance Officer & General Counsel at Establishment Labs, directs the company's legal affairs and ensures adherence to regulatory standards. Mansbach oversees all legal aspects, including corporate governance, intellectual property, and risk management, supporting Establishment Labs' global operations in medical technology. This critical role ensures that the company's Femtech solutions for breast health and reconstruction meet stringent international compliance requirements. The Chief Compliance Officer & General Counsel guides the legal framework supporting the company's extensive patent portfolio and scientific research. Mansbach manages the legal strategies that protect the company's innovations and facilitate market access for products like the Motiva Flora® tissue expander. Ross Mansbach's expertise is vital for maintaining the integrity and ethical operations of Establishment Labs.

Melissa Moreira, the Global Vice President, Human Resources at Establishment Labs, leads the company's human capital strategy and organizational development. Moreira oversees talent acquisition, employee engagement, and culture initiatives across Establishment Labs' global operations. This role is crucial for supporting the company's mission to improve women's health through its innovative Femtech solutions. The Global Vice President, Human Resources ensures that the workforce possesses the necessary expertise in science, engineering, and technology to drive product development and market expansion. Moreira manages programs that foster a collaborative environment, essential for the success of initiatives like the Motiva Flora® tissue expander and Mia Femtech. Melissa Moreira's leadership cultivates a high-performing team dedicated to advancing women's wellness worldwide.